<DOC>
	<DOCNO>NCT00123825</DOCNO>
	<brief_summary>In United States , incidence biliary tract cancer gallbladder cancer estimate 6,000-8,000 patient per year . Currently , standard therapy tumor disease spread inoperable . Recent small study gemcitabine show positive response rate . The investigator plan test combination gemcitabine cisplatin biliary tract gallbladder cancer .</brief_summary>
	<brief_title>Gemcitabine Cisplatin Gallbladder Biliary Tract Cancer</brief_title>
	<detailed_description>Gemcitabine cisplatin administer weekly two week ( day 1 day 8 ) follow one week rest period ( 1 cycle 3 week ) . On day one eight cycle patient physical exam blood work . During first two cycle , additional blood work drawn day 15 well . Reassessment tumor perform 6 week , 12 week , every 9 week thereafter . Patients remain treatment evidence disease progression unacceptable side effect occur .</detailed_description>
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Gallbladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologicallyconfirmed , locally unresectable metastatic biliary tract ( bile duct , hepatic duct , cystic duct , common bile duct , ampulla Vater ) gallbladder adenocarcinoma . Patients must least one measurable lesion great 1 cm , Response Evaluation Criteria Solid Tumors ( RECIST ) criterion outside prior radiation field . Zero one prior chemotherapy biliary tract gallbladder cancer . Prior chemoembolization liver allow long measurable disease outside chemoembolization area baseline characteristic meet . No prior gemcitabine cisplatin therapy allow . No chemotherapy within past 3 week initiation therapy ( 6 week prior therapy mitomycin C nitrosurea ) Chronological age &gt; 18 year . ECOG performance status 02 ; life expectancy &gt; 12 week . Laboratory value : ANC great equal 1500/mm3 ; platelet great equal 100,000/mm3 ; SGOT SGPT less equal 3x upper limit normal ( unless liver involved tumor , case transaminase must less equal 5 x upper limit normal ) ; total bilirubin less equal 2.0 mg/dL . Creatinine le equal 1.8 mg/dL creatinine clearance great equal 50 mL/min All patient must sign informed consent . Patients may prior placement stent shunt relieve obstruction . Patients either clinically apparent central nervous system metastases carcinomatous meningitis . Myocardial infarction past six month . Major surgery past two week . Uncontrolled serious medical psychiatric illness . Women must pregnant lactating . Both men woman childbearing potential must advise importance use effective birth control measure course study . Patients concurrent malignancy site , except limited basal cell carcinoma squamous cell carcinoma skin carcinoma situ cervix ; patient malignancy within 5 year study entry , except curatively treat basal cell carcinoma squamous cell carcinoma skin carcinoma situ cervix .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Gallbladder</keyword>
	<keyword>Biliary Tract</keyword>
	<keyword>Cholangiocarcinoma</keyword>
</DOC>